05/04/2023
Metastatic cancer patients have fewer treatment options and much poorer outcomes than patientes diagnosed at earlier stages. Sam Mazin, cofounder and CTO of RefleXion Medical, talks with SROA about his hopes and plans for his company’s SCINTIX technology to treat metastatic disease. SCINTIX received FDA clearance in February 2023.
Website: RefleXion Medical
Create your
podcast in
minutes
It is Free